Document is current
Any future updates will be listed below
-
Authors
Pagliaro, Luca https://orcid.org/0000-0001-5500-3522
Chen, Sai-Juan
Herranz, Daniel https://orcid.org/0000-0003-1768-5969
Mecucci, Cristina https://orcid.org/0000-0002-1623-0148
Harrison, Christine J.
Mullighan, Charles G. https://orcid.org/0000-0002-1871-1850
Zhang, Ming
Chen, Zhu
Boissel, Nicolas
Winter, Stuart S. https://orcid.org/0000-0003-3583-7727
Roti, Giovanni https://orcid.org/0000-0002-8664-950X
- License Information
-
More Information
Article History
Accepted: 1 May 2024
First Online: 13 June 2024
Competing interests
: C.G.M. has received research funding from Pfizer and AbbVie, has stock in Amgen, and is on an advisory board for Illumina.
